An α2 agonist that is converted to methylnorepinephrine centrally to diminish adrenergic outflow from the CNS the most common s/e are sedation and drowsiness. Its use is limited due to adverse effects and the need for multiple daily doses. It is mainly used for management of hypertension in pregnancy, where it has a record of safety.